HT
PTLA

HAP Trading’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

HAP Trading’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-279,500
Closed -$2M – 1148
2017
Q2 		$2M Buy
279,500
+267,300
+2,191% +$10.7M 0.11% 177
2017
Q1 		$83K Sell
12,200
-200
-2% -$6.37K 0.01% 593
2016
Q4 		$15K Sell
12,400
-17,900
-59% -$350K ﹤0.01% 804
2016
Q3 		$54K Buy
+30,300
New +$711K ﹤0.01% 692
2016
Q1 		– Sell
-10,000
Closed -$69K – 1144
2015
Q4 		$69K Hold
10,000
– – ﹤0.01% 602
2015
Q3 		$86K Buy
+10,000
New +$483K ﹤0.01% 628

Other funds holding PTLA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return